Solventum (SOLV) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2026, Solventum (SOLV) reported revenue of $2.01 billion, down 3% over the same period last year. EPS came in at $1.48, compared to $1.34 in the year-ago quarter.The reported revenue represents a surprise of +1.01% over the Zacks Consensus Estimate of $1.99 billion. With the consensus EPS estimate being $1.35, the EPS surprise was +9.36%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Solventum performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- MedSurg: $1.23 billion compared to the $1.21 billion average estimate based on two analysts. The reported number represents a change of +6.7% year over year.Net Sales- Health Information Systems: $342 million versus $347.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +4% change.Net Sales- Dental Solutions: $354 million versus $350.03 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +7.9% change.View all Key Company Metrics for Solventum here>>>Shares of Solventum have returned +6.6% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks